key: cord-0884410-ctp6vp39
authors: Roushani, Jian; Thomas, Doneal; Oliver, Matthew J; Ip, Jane; Tang, Yiwen; Yeung, Angie; Taji, Leena; Cooper, Rebecca; Magner, Peter O; Garg, Amit X; Blake, Peter G
title: Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes
date: 2021-11-27
journal: Clin Kidney J
DOI: 10.1093/ckj/sfab237
sha: 9695550f9f37e13cc9d87dbce035758706d904e5
doc_id: 884410
cord_uid: ctp6vp39

BACKGROUND: Severely ill people with COVID-19 are at risk of acute kidney injury treated with renal replacement therapy (AKI-RRT). Understanding of risk factors and outcomes for AKI-RRT is incomplete. METHODS: We prospectively collected data on the incidence, demographics, area of residence, time course, outcomes, and associated risk factors for all COVID-19 AKI-RRT cases during the first 2 waves of the pandemic in Ontario, Canada RESULTS: There were 271 people with AKI-RRT, representing 0.1% of all diagnosed SARS-CoV-2 cases. These included 10% of SARS-CoV-2 admissions to intensive care units (ICU). Median age was 65 years, with 11% under 50, 76% were male, 47% non-white, and 48% had diabetes. Overall, 59% resided in the quintile of Ontario neighborhoods with the greatest ethnocultural composition and 51% in the 2 lowest income quintile neighborhoods. Mortality was 58% at 30 days after RRT initiation, and 64% at 90 days. By 90 days, 20% of survivors remained RRT-dependent and 31% were still hospitalized. On multivariable analysis, people aged over 70 had higher mortality (odds ratio (OR) 2.4, 95% CI: 1.3, 4.6). Cases from the second versus the first COVID-19 wave were older, had more baseline co-morbidity, and were more likely to initiate RRT over 2 weeks after SARS-CoV-2 diagnosis (34% vs 14%, p < 0.001). CONCLUSIONS: AKI-RRT is common in COVID-19 ICU admissions. Residency in areas with high ethnocultural composition and lower socioeconomic status are strong risk factors. Late onset AKI-RRT was more common in the second wave. Mortality is high and 90-day survivors have persisting high morbidity.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of novel coronavirus disease 2019 (COVID-19) [1] . As of January 31, 2021, in Ontario, Canada's most populous province, there had been over 270,000 diagnosed infections, equivalent to 1.9% of the population, and over 6000 deaths, a case fatality rate of 2.3% [2] .

AKI is a well-recognized complication of COVID-19, with a significant proportion of those affected receiving RRT [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . AKI has been associated with direct SARS-CoV-2 infection of renal tubular cells, but the principal cause is now considered to be acute tubular injury caused by volume depletion and multi-organ failure associated with COVID- 19[7] .

The literature on people with COVID-19 related AKI-RRT is still quite limited. Gupta et al. reported a 20.6% rate of AKI-RRT in 637 people admitted to an Intensive Care Unit (ICU) in 60 hospitals across the United States (U.S.) [6] . Mortality was 55% and, of those discharged from hospital, 34% still required RRT [6] . Risk factors for mortality included older age and severe oliguria [6] .

Other AKI-RRT studies are small and single-center [10] [11] [12] . Multiple COVID-19 AKI studies have not focused specifically on patients with AKI-RRT but also report high mortality [3-5, 8, 9, 13] .

We have used prospectively collected data since the start of the pandemic in Ontario in March 2020 to look at COVID-19 AKI-RRT both inside and outside ICU in all centers in the province. We specifically looked at the demographic characteristics, including neighborhood of residence, of the AKI-RRT population, the type of RRT they received and their outcomes, the risk factors for mortality and the intervals between diagnosis of SARS-CoV-2 infection, initiation of RRT and recovery or mortality. We also examined differences between the pattern of AKI-RRT in the first and second COVID-19 waves.

Ontario has a population of about 14.5 million [15] . The Ontario Renal Network (ORN), a part of Ontario Health, is a provincial government agency that funds and manages kidney disease services working with 27 Renal Programs [16, 17] . All dialysis in Ontario, including RRT for AKI, is funded by a single-payer -the provincial government -operating through the ORN [16, 17] . For the purpose

of this study, the first wave of the pandemic in Ontario comprised the period March 1 to September 1, 2020, and the second wave from September 1, 2020, to January 31, 2021.

Nine linked data sets were used. The ORN COVID-19 data collection tool captured information each week on people with AKI-RRT after SARS-CoV-2 infection: name, health card number, type of residence, hospitalization status, RRT modality, ICU, and ventilator status, and disposition (active, recovered, deceased) [17] . This was a minimal data set but included personal health information that could be linked to other data sets. Data was collected prospectively from the second week of March 2020, when the first AKI-RRT case was diagnosed, with all Renal Programs submitting weekly data for all AKI-RRT cases. Hospital admissions were subsequently crosschecked with the Canadian Institute for Health Information Discharge Abstract Database which also allowed determination of medical histories, including comorbidities, based on the International Classification of Diseases 10 diagnostic codes. Each chronic condition was defined based on 5 years of look-back data from the date of SARS-CoV-2 reporting.

The other data sets were: Ontario Renal Reporting System, also identifying all individuals with AKI-RRT and including ethnicity, collected by data leads in each Program at registration, based on charting by clinical staff who may ask patients or relatives to self-identify ethnicity but who are not mandated to do so [17] ; Ontario Laboratories Information System, providing SARS-COV-2 test dates and results, and laboratory values generally; Registered Persons Database, providing demographic information and date of death; Ontario Health Insurance Plan, containing health insurance claims for physician services including dialysis; Statistics Canada Postal Code Conversion File, linking postal codes to standard geographic areas to derive income quintile, and also the Canadian Index of Multiple Deprivation, a geographically-based index used to understand inequalities through various metrics of education, health and society [18] . Ethno-cultural composition is a dimension represented in this Index and is defined by an area's composition of immigrant populations, including the proportions who are recent immigrants, self-identified visible minorities, born outside of Canada, and have no knowledge of Canada's official languages -English and French [18] .

All incident AKI-RRT patients registered in the ORN COVID-19 data tool between March 10, 2020, and January 31, 2021, were included. These were people who received acute RRT in association with a diagnosis of SARS-CoV-2 infection, defined as testing positive on a nucleic acid amplification test [19] . Individuals excluded were those with missing health card numbers, postal codes, non-Ontario residents, those under 18 years old, those with previous kidney transplantation or recent dialysis, and those with no serum creatinine from the previous 3 years, as it was unclear whether these were truly cases of AKI. Patients with CKD stage 5 were excluded because the degree of insult required for these patients to need RRT is likely much smaller compared to that in those with normal renal function or lesser degrees of CKD. Clinical decision making and indications for RRT were determined by individual care givers at each of the hospital/ICU sites.

Descriptive statistics included frequency (percentages) for categorical variables and means ± standard deviations (SD) or medians and interquartile ranges (IQRs) for continuous variables. Chi-squared test was used to explore the associations of categorical variables between survivors and non-survivors and between waves 1 and 2. We analyzed age above 70 as a categorical variable, thinking that this would be more useful to clinical practitioners because it reflects the intersectional experience of COVID-19 and older age[6]. To explore risk factors associated with mortality, a multivariable logistic regression was used and included sex, age, geographic location, ethnicity, diabetes, type of residence, income quintile, baseline serum creatinine, time of initiation of RRT relative to SARS-CoV-2 diagnosis, and the Canadian Index of Multiple Deprivation. Patients with an unknown, missing, or other ethnicity were treated as one distinct group and as a factorial variable with white ethnicity as the reference group. These variables were chosen based on the general literature on risk factors for COVID-19 incidence, morbidity, and mortality, and on our clinical interest as nephrologists who treat AKI. All statistical analyses were performed using SAS statistical software, with statistical significance set at two-sided P <0.05.

The The median age of the 271 people was 65 years, and 11% were aged less than 50 years, 76% were male and 79% of them were residents of the Greater Toronto Area, where just over 40% of Ontarians live (Table 1) . Overall, 92% lived in a private residence, as distinct from a congregate setting such as a nursing home. By ethnicity, 59% of the patients were either non-white or had an unknown ethnicity. Socioeconomically, 58% lived in the single most ethnocultural quintile of neighborhoods and 51% resided in neighborhoods in the 2 lowest income quintiles for Ontario (Table 1 ). Ontario's vaccination eligibility guidelines and the timing of the cases indicate that none of the 271 patients would have been fully or even partially vaccinated.

Baseline comorbidities included diabetes in 48%, a much higher rate than in the general Ontario population, cardiac disease in 20% and a previous cancer diagnosis in 9%[20] . The median baseline serum creatinine was 84 micromol/l, but 23% had baseline CKD 3 and 4% had CKD 4 (Table 1) .

Of the 271 people, 96% had an ICU stay and over 90% received mechanical ventilation. The median (IQR) interval between a first positive SARS-CoV-2 swab and initiating RRT was 9 (3-15) days. However, this varied greatly with 36% starting within 48 hours, 42% within 1 week while in contrast 31% started over 2 weeks after their first positive swab ( Figure 2 ). Regarding RRT modality, 42% received sustained low-efficiency dialysis (SLED) and 41% continuous renal replacement therapy (CRRT) at some stage in their course. These include 2.9% who received both. Conventional hemodialysis was used exclusively in 20% and in 51% at some stage in their course. The median time spent on dialysis was 4 days and was two weeks or less in 74% of patients and over two weeks in 26%

of patients. The median length of hospital stay was 18 (9-37) days (Table 2 ). In total, the 271 cases required 3177 patient days of AKI-RRT.

Of these 271 people, 174 (64%) died within 90 days of initiating RRT. Most deaths were soon after RRT initiation with 31% occurring within 7 days and 45% within 14 days. However, 18 (10%) died more than 4 weeks after starting RRT ( Figure 3 ). The mortality rate was 58% at 30 days after the start of dialysis and 62% at 60 days. Of the 174 people who died just 8 (3%) recovered renal function sufficiently to not require RRT for at least 1 week before their death. At 90 days after the start of RRT, 78 of the 97 survivors (80%) were no longer on RRT but 19 (20%) remained RRT-dependent including 14 who had been discharged from hospital and 30 (31%) were still hospitalized. In total 31% of AKI-RRT cases had recovered renal function and were discharged, 11% were alive in the hospital but not on RRT, and 7% of patients remained on RRT in hospital ( Figure 4 ).

The baseline characteristics of the 174 non-survivors and 97 survivors were compared (Table 3) . On multivariable analysis, a significantly larger proportion of patients aged 70 and older died compared to those aged 29 to 69 (odds ratio (OR) 2.4, 95% CI: 1.3, 4.6) ( Table 4 ). The relationship between age and mortality was also significant when age was analyzed as a continuous variable. There was a trend towards higher mortality in those who initiated RRT more than 2 weeks after a positive SARS-CoV-2 test as compared to RRT start within 1 week (OR 1.9, 95% CI: 1.0, 3.9, p=0.069). There were no differences between non-survivors and survivors for sex, geographic location, ethnicity, diabetes or other comorbidities, income quintile, or baseline serum creatinine, and none for type of RRT received or for time on dialysis. The relationship between ethnicity and mortality was unchanged when those with 'unknown/missing/other' ethnicity were omitted from the analysis (Appendix Table 1 ).

The incidence of AKI-RRT by time shows that there were 2 distinct periods for AKI-RRT incidence, corresponding to the 2 waves of infection seen in the general Ontario community (Figure 1 ). There was a relatively lower rate of AKI-RRT cases compared to the number of SARS-CoV-2 cases in the general population in the second wave versus the first. The characteristics and course of the 138 people diagnosed during the first wave were compared with the 133

people from the second wave (Table 5 ). In the second wave, there was a significantly higher proportion of people aged 70 or older, with cardiac disease (25 vs 15%), and with baseline CKD stages 3 and 4 (29 vs 20%). There was a significantly longer interval between the first positive SARS-CoV-2 swab and RRT initiation in the second wave with more than twice as many patients initiating RRT more than 2 weeks after diagnosis (34 vs 14%) (Table 5 ). There were no other significant differences between the baseline characteristics, treatments received and outcomes of the patients in the 2 waves.

In Ontario, 271 patients, representing 2% of hospitalizations, including 259 patients, comprising 10% of ICU admissions due to COVID-19, developed AKI-RRT in the first 11 months of the pandemic. At the 90-day follow-up, 31% of these patients recovered renal function and were discharged, 7% were still on RRT, but 64% had died, demonstrating what a devastating illness this is. Patients aged 70 and older had an even higher mortality.

These 271 people required 3,177 patient-days of acute RRT and so provided an enormous workload for already stressed ICU and Nephrology services. This is especially so since the activity was concentrated into two 6-week periods, particularly in the Toronto area, and this put enormous strain on the required human resources, especially because maintenance dialysis units were simultaneously affected by the pandemic[5, 6, 17]. Available CRRT equipment alone would not have been sufficient to provide RRT to all these people, as well as to on-going non-COVID-19 AKI-RRT cases, but many Ontario centers use SLED and conventional acute HD, and supply of machines for these modalities is relatively abundant.

A number of features stand out from the baseline demographics of the AKI-RRT population. There is a remarkable 76% male preponderance which is not seen in the general Ontario population infected with SARS-CoV-2[2]. A similar male preponderance was seen in the other COVID-19 AKI-RRT studies and to a lesser degree in other COVID-19 AKI populations [5, 6, 9, 12] . A male preponderance in AKI-RRT of other causes has recently been reported [21] . Almost 50% of the AKI-RRT cohort had baseline diabetes, similar to the 53% noted in the U.S. study but far in excess of the 10% prevalence of diabetes in the Ontario adult population [6, 20] . With regard to ethnicity, 41% of the AKI-RRT population were identified as white, as compared to 68% in the general Ontario[11] . However, ethnicity data was missing in 22% of the cohort. The ratio of those identified as white compared to non-white was 1.12 in the AKI-RRT cohort compared to 2.14 in the general population [13] . More strikingly, almost 60% of people with AKI-RRT came from the quintile of neighborhoods with the greatest degree of ethnocultural composition in Ontario and almost 80% from the 2 most socioeconomically deprived quintiles [14] . These neighborhoods often have high rates of multigenerational households and of high-density workplaces. All this is consistent with risk factors for SARS-CoV-2 infection and its complications reported elsewhere and emphasizes the socioeconomic and ethnocultural factors underlying so much of the COVID-19 pandemic's worst effects in many countries [17, [22] [23] [24] [25] [26] . The need for strategies to protect these vulnerable populations is apparent and, in addition to vaccination, might also include focused workplace and community interventions [17, [24] [25] [26] .

The mortality rate of 64% and the renal function recovery rate of 31% in this study were both higher those reported in the U.S. multicenter study but this may just reflect longer follow-up[6]. The association of older age with mortality was expected[6]. The combination of a 31% rate of persisting hospitalization and a 19% rate of continuing RRT-dependence in 90-day survivors emphasizes the lasting morbidity associated with this condition. The high mortality with COVID-19 AKI-RRT is not much different from that in other types of sepsisassociated AKI-RRT[6, 7, 9]. The absence of any correlation between baseline co-morbidities and mortality likely indicates the overwhelming influence of the severity of the infection on outcome in this population and was also seen in the U.S. AKI-RRT study [6] .

When comparing AKI-RRT in the 2 waves of COVID-19, we found a lower rate of AKI-RRT cases compared to the number of infections in the general population in the second wave versus the first. The decreasing incidence of AKI-RRT and of AKI in general throughout the pandemic has been reported from the U.S and Switzerland[27, 28]. The relatively lower rate of AKI-RRT in the second wave may also reflect the lower availability of SARS-CoV-2 testing in the community during the first wave. This suggests that AKI-RRT may be preventable through better initial management of COVID-19. We found in the second wave a higher proportion of people with AKI-RRT aged 70 or older, with cardiac disease, and with baseline CKD 3 and 4. We found no other studies comparing AKI-RRT cases between successive COVID-19 waves, although a single center ICU study in France found no differences between their first two

waves in age or co-morbidity [29] . One hypothesis is that improvements in COVID-19 management after the first wave helped reduce AKI-RRT in patients with fewer risk factors, giving greater predominance to those who were more vulnerable with older age, and more comorbidity. The difference in time course to development of AKI-RRT with more than twice as high a proportion of cases occurring more than 2 weeks after diagnosis of COVID-19 in the second wave is important. It may be that better initial management of COVID-19 is avoiding some of the early AKI-RRT related to fulminant infection allowing patients to survive longer, but some then develop late onset AKI-RRT due to the cumulative renal insults that occur during a prolonged ICU stay.

Our study has a number of strengths. Our data comes from an entire province of over 14 million people. The single-payer public funding and delivery of dialysis and acute hospitalization in Ontario makes it possible to report reliably and in detail on the entire population of patients who received AKI-RRT due to COVID-19, in contrast to hospital-based studies which may not account for all cases in a region [6, [9] [10] [11] [12] . This included the small proportion of cases who received AKI-RRT outside ICU who were not included in other studies [6] . Prospective weekly reporting of cases from the start of the pandemic allowed for more accurate capture of incidence and outcomes over time, including follow-up data on survivors to accurately determine dialysis dependence after 90-day follow-up.

There are several limitations to this study. First, the absence of a detailed database with the characteristics of the general population infected with SARS-CoV-2 precludes detailed comparisons with the AKI-RRT population. Second, the results of this study may not be generalizable to other jurisdictions due to differences in population characteristics, healthcare resources, and variant strains of SARS-CoV-2. Third, only studying AKI-RRT patients excludes cases where RRT was theoretically indicated but not received due to decisions by stakeholders in the patient's health.

In conclusion, this prospective cohort study comprises all patients with AKI-RRT associated with COVID-19 in Ontario, Canada. We describe a high incidence among critically ill COVID-19 patients and an associated high mortality, especially in older patients, and a high rate of non-recovery of renal function and persisting hospitalization in survivors. The AKI-RRT population is more likely to be male, to have diabetes, to be of non-white ethnicity and to live in areas with higher rates of ethnocultural and economic deprivation. This study

emphasizes socioeconomic and ethnic predisposition to severe COVID-19 and consequent AKI-RRT.

Thank you to the Ontario Regional Renal Programs and all associated individuals submitting data each week for their efforts to serve those with kidney disease. Note When number of cases is < 6, the exact number cannot be stated for Ontario Health privacy reasons

Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery

Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury

COVID-19-Associated Acute Kidney Injury: Learning from the First Wave

COVID-19 in patients undergoing longterm dialysis in Ontario

The Canadian Index of Multiple Deprivation

Ontario Ministry of Health. COVID-19 Quick Reference Public Health Guidance on Testing and Clearance

Diabetes Canada

Sex differences in acute kidney injury requiring dialysis

Clinical Risk, Sociodemographic Factors, and SARS-CoV-2 Infection Over Time in Ontario

COVID-19: Exposing and addressing health disparities among ethnic minorities and migrants

The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States

Economic, and Health Inequality and COVID-19 Infection in the United States

Racial and Neighborhood-Level Disparities in COVID-19 Incidence among Patients on Hemodialysis in New York City